Ten63 Therapeutics
Michele is the Senior VP of Preclinical Development at Ventus Therapeutics. She earned her PhD in Molecular Immunology from UT Southwestern Medical Center, and has 20 years of experience in pharmaceutical development with 8 drug approvals and over a dozen initial INDs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ten63 Therapeutics
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.